saxagliptin

英語（米国） (en-US) 英語（イギリス） (en-GB)

IPA（発音記号）

/ˌsæk.səˈɡlɪp.tɪn/

名詞

不可算名詞

(pharmacology) A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze.

このボタンはなに？

After reviewing the patient's history, the endocrinologist decided to start saxagliptin to help improve glycemic control.

詳細

意味（1）

(pharmacology) A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze.